The role of TET1 in cholangiocarcinoma was investigated in 2021 by Bai et al.91The study demonstrated that TET1, which depends on 2-oxoglutarate (OG), is significantly up-regulated in cholangiocarcinoma patients. Here, TET1 is linked to cholangiocarcinoma.